Skip to main content
. 2020 Nov 16;20:1721. doi: 10.1186/s12889-020-09830-y

Table 2.

Between group differences in the mean changes of the SF-36 scores from baseline to each follow-up

Δ (Baseline to Midpoint) Δ (Baseline to Endpoint) Δ (Baseline to 1 year)
SF-36 domains (score) β coefficient (95% CI)a β coefficient (95% CI)a β coefficient (95% CI)a
Physical functioning −1.49 (− 9.05, 6.06) −7.12 (− 15.34, 1.10) −1.93 (− 12.16, 8.29)
Physical role functioning −7.66 (− 24.04, 8.73) - 13.93 (− 30.33, 2.48) 0.35 (− 21.09, 21.79)
Bodily pain −1.45 (− 15.02, 12.12) −6.94 (− 19.75, 5.86) 2.16 (− 13.16, 17.49)
General health −0.33 (− 14.80, 14.15) −7.69 (− 21.13, 5.74) 2.64 (− 14.12, 19.40)
Vitality −2.65 (− 13.73, 8.42) −8.85 (− 21.20, 3.49) −1.01 (− 15.37, 13.35)
Social functioning −1.23 (− 17.16, 14.69) −3.81 (− 9.80, 17.41) 2.05 (− 15.20, 19.31)
Emotional role functioning −14.68 (− 29.61, 0.26) - 16. 01 (− 32.46, 0.45) − 7.71 (− 26.07, 10.65)
Mental health 4.41 (− 4.33, 13.15) − 5.44 (− 15.65, 4.77) 7.11 (− 4.22, 18.43)
Physical component summary −0.82 (− 5.81, 4.17) −3.06 (− 7.81, 1.68) 0.09 (− 6.27, 6.46)
Mental component summary −1.65 (− 6.65, 3.36) −3.62 (− 8.96, 1.72) 0.57 (− 5.58, 6.72)

a β coefficients of the linear regression models in intention-to-treat analysis with supervised health program as reference, n = 89; Abbreviations: CI Confidence intervals